---
title: "Elder Health Care Ltd (524830) — Share Price, Financials & Analysis"
symbol: "524830"
company: "Elder Health Care Ltd"
canonical: "https://tapetide.com/stocks/524830"
isin: "INE950E01010"
bse_code: "524830"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:58:26.098Z"
---

# Elder Health Care Ltd (524830)

Canonical page: https://tapetide.com/stocks/524830

## Company

- **BSE Code:** 524830
- **ISIN:** INE950E01010
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** elderhealthcare.in

## About

Elder Health Care Limited, incorporated in India, listed on the Bombay Stock Exchange Limited, the company is engaged in deals in pharmaceuticals & related products

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.83% over past five years.
- Company has high debtors of 229 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | -112% | — | — |
| revenue growth | -95% | -15% | 7% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 40.76 | 37.07 | 36.46 | 25.2 | 7.99 | 1.05 | 2.69 | 1.68 | 0.4 |
| Expenses | 38.53 | 35.01 | 34.81 | 24.26 | 10.3 | 5.37 | 4.76 | 2.48 | 1.13 |
| Operating Profit | 2.23 | 2.06 | 1.65 | 0.94 | -2.31 | -4.32 | -2.07 | -0.8 | -0.73 |
| OPM % | 5.47 | 5.56 | 4.53 | 3.73 | -28.91 | -411.43 | -76.95 | -47.62 | -182.5 |
| Other Income | 0.06 | 0.09 | 0.01 | 0.02 | 0.02 | -20.01 | -10.05 | 0 | 0.01 |
| Interest | 1.8 | 2.34 | 2.03 | 2.27 | 2.32 | 2.03 | 1.72 | 1.58 | 1.59 |
| Depreciation | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.22 | 0.23 | 0.23 | 0.23 |
| Profit before tax | 0.26 | -0.42 | -0.6 | -1.54 | -4.84 | -26.58 | -14.07 | -2.61 | -2.54 |
| Tax % | -126.92 | -9.52 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 |
| Net Profit | 0.59 | -0.38 | -0.6 | -1.54 | -4.84 | -26.62 | -14.08 | -2.61 | -2.54 |
| EPS in Rs | 1.48 | -0.95 | -1.5 | -3.85 | -12.1 | -66.55 | -35.2 | -6.52 | -6.35 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 15m | Jun 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 38 | 46 | 68 | 51 | 80 | 114 | 153 | 187 | 71 | 6 |
| Expenses | 50 | 52 | 66 | 49 | 79 | 107 | 140 | 173 | 75 | 14 |
| Operating Profit | -12 | -6 | 2 | 1 | 2 | 7 | 13 | 13 | -4 | -8 |
| OPM % | -31 | -13 | 2.3 | 2.8 | 2.1 | 6 | 9 | 7 | -6 | -136 |
| Other Income | 13 | 8 | 1 | 1 | 2 | 1 | 0 | 0 | -19 | -30 |
| Interest | 1 | 1 | 2 | 2 | 3 | 5 | 8 | 11 | 9 | 7 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 0 | 0 | 1 | 0 | 0 | 2 | 4 | 2 | -32 | -46 |
| Tax % | 233 | 12 | 9 | 51 | 29 | 31 | -2 | 1 | 4 | — |
| Net Profit | 0 | 0 | 0 | -1 | 0 | 2 | 4 | 2 | -34 | -46 |
| EPS in Rs | -0.7 | 0.75 | 1.25 | -1.4 | 0.12 | 4.02 | 11.18 | 4 | -84.02 | -114.62 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 0 | 1 | 1 | 1 | 1 | 2 | 7 | 8 | -25 |
| Borrowings | 17 | 19 | 25 | 18 | 31 | 41 | 68 | 53 | 56 |
| Other Liabilities | 18 | 20 | 26 | 32 | 19 | 25 | 35 | 29 | 44 |
| Total Liabilities | 40 | 44 | 56 | 54 | 55 | 73 | 114 | 95 | 79 |
| Fixed Assets | 4 | 6 | 5 | 15 | 14 | 14 | 13 | 12 | 12 |
| CWIP | 0 | 2 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 11 | 12 | 12 | 10 | 8 | 8 | 8 | 6 | 6 |
| Other Assets | 24 | 25 | 30 | 29 | 32 | 50 | 92 | 76 | 61 |
| Total Assets | 40 | 44 | 56 | 54 | 55 | 73 | 114 | 95 | 79 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -2 | -5 | 1 | 9 | -15 | -6 | -6 | 12 | 5 |
| Cash from Investing Activity | 2 | 0 | -6 | 1 | 3 | 1 | 0 | 2 | 0 |
| Cash from Financing Activity | 2 | 3 | 6 | -10 | 11 | 5 | 6 | -14 | -5 |
| Net Cash Flow | 3 | -3 | 1 | 0 | -1 | 0 | -1 | 0 | 0 |
| Free Cash Flow | -2 | -9 | -6 | 8 | -15 | -6 | -7 | 12 | 5 |
| CFO/OP | 12 | 91 | 39 | 671 | -875 | -70 | -48 | 88 | -144 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Jun 2013 | Jun 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 48 | 41 | 44 | 67 | 55 | 77 | 149 | 106 | 229 |
| Inventory Days | 144 | 154 | 113 | 144 | 120 | 115 | 104 | 48 | 83 |
| Days Payable | 119 | 115 | 107 | 176 | 104 | 102 | 98 | 52 | 210 |
| Cash Conversion Cycle | 72 | 80 | 50 | 35 | 71 | 91 | 155 | 102 | 102 |
| Working Capital Days | 9 | 23 | 10 | -36 | 57 | 84 | 136 | 91 | 89 |
| ROCE % | — | -9 | 8 | 6 | 8 | 17 | 20 | 18 | -9 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.17% | 60.17% | 70.16% | 55.83% | 65.34% | 70.23% | 60.24% | 51.97% | 38.08% | 38.08% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.02% | 0.31% | 0% |
| DIIs | 0% | 0.14% | 0.01% | 0.01% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 39.83% | 39.68% | 29.83% | 44.16% | 34.66% | 29.77% | 39.76% | 48.01% | 61.61% | 61.93% |
| No. of Shareholders | 18071 | 18519 | 19342 | 19381 | 19021 | 31181 | 46535 | 52603 | 72453 | 72169 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60.24% | 60.24% | 60.24% | 59.66% | 51.97% | 51.97% | 51.97% | 41.62% | 38.08% | 38.08% | 38.08% | 38.08% |
| FIIs | 0% | 0% | 0% | 0.02% | 0.02% | 0.01% | 0.04% | 0.35% | 0.31% | 0.32% | 0% | 0% |
| Public | 39.76% | 39.75% | 39.76% | 40.31% | 48.01% | 48.03% | 47.99% | 58.04% | 61.61% | 61.59% | 61.92% | 61.93% |
| No. of Shareholders | 46535 | 46344 | 46377 | 49574 | 52603 | 53317 | 66499 | 71741 | 72453 | 72181 | 72149 | 72169 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 112.44 | Sell |
| EMA (10) | 111.83 | Sell |
| SMA (20) | 115.21 | Sell |
| EMA (20) | 114.32 | Sell |
| SMA (50) | 121.12 | Sell |
| EMA (50) | 120.21 | Sell |
| SMA (100) | 129.4 | Sell |
| EMA (100) | 128.67 | Sell |
| SMA (200) | 144.34 | Sell |
| EMA (200) | 145.22 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 33.56 | Neutral |
| MACD (12,26,9) | -3.15 | Sell |
| Stochastic (14,3,3) | 43.5 | Neutral |
| ADX (14) | 35.86 | Buy |
| Williams %R (14) | -65.33 | Neutral |
| ATR (14) | 5.91 | High Volatility |
| ROC (12) | -7.93 | Sell |
| Stoch RSI (14) | 40.49 | Neutral |
| UO (7,14,28) | 50.56 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8h - Virtual investor/analyst group meeting on March 12, 2026 at 5:00 PM; no UPSI shared. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8h - Virtual investor/analyst group meeting on March 12, 2026 at 5:00 PM; no UPSI shared.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/beba9da7-d116-4c79-91c3-40d86fe49a1b.pdf) |
| 14 Feb - Q3/9M FY26 results: Q3 income ₹94.31Cr, 9M ₹321.18Cr; launched IQ Energy AI; carbon capture R&D. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 14 Feb - Q3/9M FY26 results: Q3 income ₹94.31Cr, 9M ₹321.18Cr; launched IQ Energy AI; carbon capture R&D.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4c35d7a7-f245-4c1c-8f40-853b3d434931.pdf) |
| 14 Feb - Audio recording of Q3 and nine-month FY26 earnings call uploaded to company website (Feb 13, 2026). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 14 Feb - Audio recording of Q3 and nine-month FY26 earnings call uploaded to company website (Feb 13, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12ef724b-601f-4ca8-9cb2-99fed698b203.pdf) |
| 12 Feb - Approved unaudited Q3 and nine-month results to 31 Dec 2025; limited review; Rs.500 lakh investment disclosure. | [Board Meeting Outcome for Outcome Of Board Meeting For Q3 Of 2025-2026 12 Feb - Approved unaudited Q3 and nine-month results to 31 Dec 2025; limited review; Rs.500 lakh investment disclosure.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/734eecff-d76b-4a5f-b095-887b867cb678.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 18 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87047e5a-eb87-4583-928a-5be7da610bca.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2a92ef2-2adf-4918-86f6-40bd35a702f1.pdf) |
| — | [Un-Audited Financial Results For Q3 Of 2025-2026 12 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachLive/88600723-7bb9-41c7-b8cf-386f419f81c4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a269957f-c06a-4b5f-aca2-71c6051589f7.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e95e6773-4558-43f1-aecc-39d9b4380f63.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5df42a11-8538-4367-8feb-6adee71dffcf.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/76720534674.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/69655534674_18_09_21.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/67064534674.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/5346740319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/5346740318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/5346740317.pdf) |
| from bse | [Financial Year 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/534674/5346740316.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Feb 2017 | [Concall - Feb 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7E3D4E13_7F1E_415D_95A1_B47B127E2629_180702.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:26.098Z.